The stock of International Flavors & Fragrances (IFF) has experienced stable analyst ratings, with recent evidence of positive sentiment despite market volatility. Analyst ratings depict a notable confidence in the company's industry position, supported by its innovative product segments in Nutrition, Fragrances, Health & Biosciences, and Pharma Solutions.
Analyzing recent data, IFF's stock shows a consistent level of support from analysts, with the majority rating it as a "Buy" or "Strong Buy". At the beginning of April 2025, the stock recorded 5 Strong Buy, 12 Buy, 5 Hold, 1 Sell, and 0 Strong Sell ratings. This positive sentiment is complemented by a robust score bar indicating strong market confidence.
Rating Type | Count | Score |
---|---|---|
Strong Buy | 5 | |
Buy | 12 | |
Hold | 5 | |
Sell | 1 | |
Strong Sell | 0 |
Over the recent months, the analyst sentiment on IFF has reflected a slight increase in positive outlooks, particularly within the Buy ratings category. In general, the total number of recommendations has remained steady, suggesting stable interest and confidence in the stock. Trends show a fluctuating yet balanced view between Strong Buy and Buy ratings, with minimal shifts in Hold and Sell categories.
The rating distribution for IFF indicates subtle shifts over recent periods, most notably the gradual increase in Buy recommendations. This shift highlights an emerging positive stance from analysts, reflecting a cautious yet optimistic outlook. Analysis shows diminishing Hold ratings parallel to progressive Buy recommendations.
The latest recommendations for IFF reflect a prevailing positive sentiment. Despite the absence of new Upgrades, the consistent "Outperform" and "Overweight" ratings sustain investor confidence.
Date | New Recommendation | Last Recommendation | Publisher |
---|---|---|---|
2025-04-22 | Outperform | Outperform | Oppenheimer |
2025-04-15 | Outperform | Outperform | Mizuho |
2025-04-14 | Equal Weight | Equal Weight | Barclays |
2025-04-10 | Overweight | Overweight | Morgan Stanley |
2025-04-10 | Buy | Buy | Stifel |
Recent months have seen key upgrades, indicating increased confidence in IFF's market position. Such movements suggest stronger forward-looking expectations from analysts.
Date | New Recommendation | Last Recommendation | Publisher |
---|---|---|---|
2025-01-07 | Buy | Hold | Argus Research |
2024-11-12 | Overweight | Equal Weight | Morgan Stanley |
2024-11-07 | Buy | Hold | Vertical Research |
2024-09-03 | Outperform | Neutral | Mizuho |
2024-07-22 | Buy | Hold | Stifel |
The current analyst sentiment regarding IFF stock hints at continued confidence in its strategic initiatives and market adaptability. The shift towards more favorable recommendations over the past year highlights a potential uptick in growth or stability within its sectors. Observations suggest a moderate-to-high level of analyst confidence, with limited evidence of growing uncertainty.
Overall, IFF demonstrates steady support from analysts, characterized by a balanced distribution of Buy and Hold recommendations. The company's diverse product segments and strategic market position likely contribute to sustained analyst interest and endorsements. Nonetheless, while the outlook remains positive, the presence of Hold recommendations signals cautious optimism. This analysis suggests that IFF holds both opportunities and risks, in alignment with fluctuating market dynamics and consumer demand trends.